Related Experiment Videos
Cyclooxygenase-dependent signalling: molecular events and consequences
H H Versteeg1, P M van Bergen en Henegouwen, S J van Deventer
1Laboratory for Experimental Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands.
FEBS Letters
|March 9, 1999
Summary
Non-steroidal anti-inflammatory drugs (NSAIDs) offer pain relief and possess anti-thrombotic and anti-oncogenic effects. This review explores how NSAIDs, by inhibiting prostanoid production, impact cellular signaling through G protein-coupled receptors, corticosteroid-like receptors, and tyrosine kinase pathways.
Area of Science:
- Pharmacology
- Molecular Biology
- Biochemistry
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain relief.
- NSAIDs also exhibit significant anti-thrombotic and anti-oncogenic properties.
- Their mechanism involves inhibiting cyclooxygenase, an enzyme crucial for prostanoid production.
Purpose of the Study:
- To review the multifaceted roles of prostanoid signaling in cellular physiology.
- To evaluate the relevance of prostanoid signaling in various (patho)physiological processes.
- To elucidate the three distinct levels at which prostanoids influence cellular functions.
Main Methods:
- Literature review of existing research on NSAIDs and prostanoid signaling.
- Analysis of prostanoid interactions with G protein-coupled receptors.
- Examination of prostanoid effects on corticosteroid-like receptors and protein tyrosine kinase signaling pathways.
Main Results:
- Prostanoids modulate cellular physiology via three primary mechanisms.
- These mechanisms include activation of G protein-coupled receptors, modulation of corticosteroid-like receptors, and involvement in tyrosine kinase signaling.
- NSAID-induced inhibition of prostanoids impacts these signaling cascades.
Conclusions:
- Prostanoid signaling is a complex process with implications beyond inflammation.
- Understanding these signaling pathways is crucial for appreciating the broader therapeutic potential of NSAIDs.
- Further research into prostanoid signaling can uncover new therapeutic strategies for thrombotic and oncogenic conditions.